FIMARA-2.5
FIMARA-2.5 an anti-estrogen of the Aromatase Inhibitor (AI) family and
is one of the most potent and powerfully effective of all AI’s. In fact, its
potency is sometimes too much for some to handle when used for off
label use. Letrozole first gained U.S. FDA approval in 1997 and would
Although Femara is the dominating trade name of the AI, unlike most AI’
s it is the only one generally known by its chemical name Letrozole far
more commonly than its dominating brand name.
Letrozole was first developed in an effort to combat breast cancer in
post-menopausal women. In fact, it would prove to be virtually identical
to the already popular AI in Arimidex (Anastrozole). While intended for
breast cancer treatment, like many AI’s, it has found a welcomed home
among anabolic steroid users. Letrozole is one of the most commonly
used anti-estrogens among steroid users during steroid use to combat
possible estrogenic related side effects. It is so effective as an anti-
estrogen in this regard many anabolic steroids have effectively
reversed gynecomastia symptoms with Letrozole.
Presentation:
2.5mg tablets . Sealed in a 50 tablets Foil pack.
